Background: Dual-acting human monoamine oxidase B (hMAO-B) and cholinesterase (ChE) inhibitors are more effective than the classic one-drug one-target therapy for Alzheimer's disease (AD).
Methods: The ChE inhibitory ability of some halogenated thiophene chalcone-based molecules known to be selective hMAO-B inhibitors was evaluated.
Results: Based on the IC50 values, the selected compounds were found to moderately inhibit ChE, with IC50 values in the range of 14-70 µM. Among the synthesised molecules, T8 and T6 showed the most potent inhibitory activity against AChE and BChE, respectively.
Conclusion: Taken together, the data revealed that T8 could be further optimized to enhance its AChE inhibitory activity.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.2174/1871524918666181119114016 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!